Research & Development



  “真的很美啊。”   他從來都不相信雲瑯說的關于雲氏一心只想要大漢國變得強大的屁話。97超碰色视频在线观看   雲哲終于在未央宮擁有了一個矮幾,一個小小的蒲團,以及筆墨紙硯。超碰公开视频在线观看   正在吃飯的梁贊端著飯碗的手劇烈顫抖了一下,終于沒有停下進食,短時間過後,他的手就不再顫抖,顯得堅定無比。   “孤王百思不得其解,問過我母後,問過我舅舅,舅母,他們都啞口不言。啞口不言難道就能阻礙我知道事情真相嗎?我無論如何都想不到,導致我陷入如此地步的原因不是我劉據不夠好,也不是我劉據做了一些倒行逆施的事情,真正的原因居然是因為我父皇見不得我這個年長的太子!”chaopeng超碰公开视频   “我不想去父皇那里!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo